Both in Pharmaceuticals
Korsana Biosciences vs Ocular Therapeutix
Over the past year KRSA returned −0.8% and OCUL returned −35.8%; their daily moves had a correlation of 0.21.
KRSA −0.8% OCUL −35.8%Growth of $1, one year, split-adjusted
| Metric | KRSA | OCUL |
|---|---|---|
| Price | $31.66 | $6.73 |
| Market cap | $1.44B | $1.48B |
| Today | +5.04% | −3.44% |
| 1 month | +3.8% | −3.3% |
| 6 months | — | −31.1% |
| Year to date | — | −44.6% |
| 1 year | — | −43.1% |
| Revenue growth (YoY) | — | +0.1% |
| Gross margin | — | 85.1% |
| Net margin | — | −584.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 28.4× |
| Net cash | — | $525.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 75.6% |
| Short % of float | 1.0% | 15.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).